MEDICINAL PLANTS FOR THE TREATMENT OF ALZHEIMER’S DISEASE: CURRENT TREATMENT & FUTURE PERSPECTIVE

Main Article Content

AFREEN HASHMI
VIVEK SRIVASTAVA
PEEUSH SINGHAL

Abstract

Alzheimer's disease (AD) is a disorder of brain which progressively weakens the cognitive function. It is occur due to formation of β amyloid plaques & neurofibrillary tangles, & cholinergic neurotransmitter degeneration. At present there is no cure for this disease but currently it can be controlled by using a drugs which symptomatically treat the AD involve N-methyl D-aspartate (NMDA) receptor antagonist (memantine) & Acetylcholinesterase inhibitors (AChEIs) (donepezil, rivastigmine, galantamine). Natural treatment comprising various medicinal plants & herbs are utilize to treat brain disorders like dementia, amnesia, and AD from ancient time. Preclinical & clinical studies both are confirmed the therapeutic potential of herbal product for inhibition of AD. Medicinal plants shown effectiveness against Alzheimer’s probably because of their pleiotropic & multiple action which involves antioxidants, anti-inflammatory & neuroprotective activity. In this present review we focuses on the therapeutic potential of various medicinal plants which significantly contributed for treating AD & memory deficits.

Keywords:
Medicinal plants, antioxidant, neuroprotective action, neurofibrillary tangles

Article Details

How to Cite
HASHMI, A., SRIVASTAVA, V., & SINGHAL, P. (2022). MEDICINAL PLANTS FOR THE TREATMENT OF ALZHEIMER’S DISEASE: CURRENT TREATMENT & FUTURE PERSPECTIVE. Journal of International Research in Medical and Pharmaceutical Sciences, 17(3), 30-41. https://doi.org/10.56557/jirmeps/2022/v17i38008
Section
Review Article

References

Francis PT, Palmer AM, Snape M, Wilcock GK. The cholinergic hypothesis of Alzheimer’s disease:A review of progress. Journal of Neurology, Neurosurgery and Psychiatry. 1999;66:137-147.

Dastmalchi K, Dorman HJD, Vuorela H, Hiltunen R. Plants as potential sources for drug development against Alzheimer’s disease. International Journal of Biomedical and Pharmaceutical Sciences. 2007;1(2):83–104.

Mattson MP. Pathways towards and away from Alzheimer’s disease. Nature. 2004;430 (7000):631–639.

alzheimer’s disease. mayo clinic. mayo foundation for medical education and research; 2018.

Availaable:https://www.mayoclinic.org/diseases-conditions/alzheimers-disease/symptoms-causes/syc-20350447.

Lippincott, Williams, Wilkins. "Alzheimer disease drugs." Nursing 2010 Drug Handbook. Philadelphia: Wolters Kluwer Health. 2010;546-551.

Rao RV, Descamp O, John V, Bredesen DE. Ayurvedic medicinal plants for Alzheimer’s disease:a review. Alzheimer’s Research & Therapy. 2012;4(22):2-9.

Singh RH, Narsimhamurthy K, Sing h G. Neuronutrient impact of Ayurvedic Rasayana therapy in brain aging. Biogerontology. 2008;9:369-374.

Jayaprakasam B, Padmanabhan K, Nair MG. Withanamides in Withania somnifera fruit protect PC‑12 cells from beta‑ amyloid responsible for Alzheimer’s disease. Phytotherapy Research. 2010;24: 859‑63.

Mishra LC, Singh BB, Dagenais S. Scientifi c basis for the therapeutic use of Withania somnifera (Ashwagandha): a review. Alternative Medicine Review. 2000;5:334- 346.

Cole GM, Lim GP, Yang F, Teter B, Begum A, Ma Q, Harris-White ME, Frautschy SA. Prevention of Alzheimer’s disease:omega-3 fatty acid and phenolic anti-oxidant interventions. Neurobiology of Aging. 2005;26 Suppl 1:133-136.

Lim GP, Chu T, Yang F, Beech W, Frautschy SA, Cole GM. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. Journal of Neuroscience. 2001;21: 8370-8377.

Yang F, Lim GP, Begum AN, Ubeda OJ, Simmons MR, Ambegaokar SS, Chen PP, Kayed R, Glabe CG, Frautschy SA, Cole GM. Curcumin inhibits formation of amyloid beta oligomers and fi brils, binds plaques, and reduces amyloid in vivo. Journal of Biological Chemistry. 2005;280:5892-5901.

Shinomol GK, Muralidhara, Bharath MM. Exploring the role of ‘Brahmi’ (Bocineopa monnieri and Centella asiatica) in brain function and therapy. Recent Patents on Endocrine, Metabolic and Immune Drug Discovery. 2011;5:33-49.

Singh HK, Dhawan BN. Effect of Bacopa monniera Linn. (Brahmi) extract on avoidance responses in rat. Journal of Ethnopharmacology. 1982;5:205-214.

Uabundit N, Wattanathorn J, Mucimapura S, Ingkaninan K. Cognitive enhancement and neuroprotective effects of Bacopa monnieri in Alzheimer’s disease model. Journal of Ethnopharmacology. 2010;127:26-31.

Bhattacharya SK, Bhattacharya A, Kumar A, Ghosal S:Antioxidant activity of Bacopa monniera in rat frontal cortex, striatum and hippocampus. Phytotherapy Research. 2000;14:174-179.

Limpeanchob N, Jaipan S, Rattana karuna S, Phrompittayarat W, Ingkaninan K:Neuroprotective eff ect of Bacopa monnieri on beta-amyloid-induced cell death in primary cortical culture. Journal of Ethnopharmacology. 2008;120:112-117.

Warrier PK, Nambiar VPK, Ramankutty C, editors. Indian medicinal plants:a compendium of 500 species. India:Sangam Books. 1996;46(11).

Houghton P, Howes MJ. Natural products and derivatives affecting neurotransmission relevant to Alzheimer’s and Parkinson’s disease. Neurosignals. 2005;14(1-2):6-22.

Patwardhan B, Ashok DB, Chorghade M. Ayurveda and Natural Products Drugs Discovery. Current Science. 2004;86(6):789 – 799.

Andrzejewska J, Ignaczak S, Katańska-Kaczmarek A, Barzyk P. Crude fat content and fatty acid profile in the seeds of polish lines and cultivars of field pea (Pisum sativum L.): Pilot Study. EJPAU. 2015;18(4):07.

Kaura S, Parle M. Evaluation of nootropic potential of green peas in mice. Journal of Applied Pharmaceutical Science. 2017; 7(5):166-173.

Nemalapalli Y et al. Effect of ethanolic seed extract of Bauhinia purpurea linn on cognition in scopolamine induced Alzheimer’s disease rat’s model. Journal of Comprehensive Pharmacy. 2015;2(4):145-150.

Kumar A, Ilavarasan R, Jayachandran T, Decaraman M, Aravindha P. Phytochemical investigation on a tropical plant, Syzygium cumini from Kattupalayam, Erode district, Tamilnadu, South India. Pakistan Journal of Nutrition. 2009;8:83–85.

Rekha Namasivayam, Balaji Ramachandran, Deecaraman Munuswamy. Effect of aqueous extract of Syzygium cumini pulp on antioxidant defense system in streptozotocin induced diabetic rats. Iranian Journal of Pharmacology & Therapeutics. 2008;7:137–145.

Modi DC, Patel JK, Shah BN, Nayak BS. Antiinflammatory activity of seeds of Syzygium cumini linn. American Journal of Pharmaceutical Education. 2010;1:68–70.

Alikatte KL, et al. Antiamnesic activity of Syzygium cumini against scopolamine induced spatial memory impairments in rats. Brain & Development. 2012;34:844–851.

Zhang L, Huang Y, Lu L, Wai MSM, Chan WM, Yew DT. Effects of DL-3-n-Butylphthalide on Vascular Dementia and Angiogenesis. Neurochemical Research. 2012;37:911-919.

Iswantini D, Ramdhani TH, Darusman LK. In vitro inhibition of celery (Apium graveolens L.) extract on the activity of Xanthine oxidase and determination of its active compound. Indonesian Journal of Chemistry. 2012;12(3):247-254.

Misic D, Zizovic I, Stamenic M, Asanin R, Ristic M, Petrovic SD, Skala D. Antimicrobial activity of celery fruit isolates and SFE process modeling. Biochemical Engineering Journal. 2008;42:148-152.

Phetcharat B, Wanida S, Supita T, Pennapa, C. Ameliorative effect of Apium graveolens Linn on scopolamine-induced amnesia mice. The International Conference on Herbal and Traditional Medicine. 2015;82-93.

Gokhale AB, Damre AS, Kulkarni KR, Saraf MN. Preliminary evaluatin of anti-inflammatory and anti-arthritic activity of S. lappa, A. speciosa and A. aspea. Phytomedicine. 2002;9:433-437.

Gokhale AB, Damre AS, Saraf MN. Investigation into the immunomodulatory activity of Argyreia speciosa. Journal of Ethnopharmacology. 2003;84:109-114.

Hanumanthachar J, Navneet K, Jyotibala C. Evaluation of nootropic effect of Argyreia speciosa in mice. Journal of Health Science. 2007;53(4):382-388.

Ahameethunisa AR, Hopper W. Antibacterial activity of Artemisia nilagirica leaf extracts against clinical and phytopathogenic bacteria. BMC Complementary and Alternative Medicine. 2010;10(6):1-6.

Xie G, Schepetkin IA, Siemsen DW, Kirpotina LN, Wiley JA. Fractionation and Characterization of Biologically-active Polysaccharides from Artemisia tripartite. Phytochemistry. 2008;69:1359-1371.

Uniyal GC, Singh AK, Shah NC, Naqvi AA. Volatile constituents of Artemisia nilagirica. Planta medica. 1985;51(5):457-458.

Haider F, Naqvi AA, Bagchi GD. Oil constituents of Artemisia nilagirica var. septentrionalis during different growth phases at subtropical conditions of North Indian plains. Journal of Essential Oil Research. 2007;19(1):5-7.

Pal G, Pradeep AK. Antioxidant, Anti-alzheimer and Anti- Parkinson of Artemisia nilagirica Leaves with flowering tops. UK Journal of Pharmaceutical and Biosciences. 2018;6(2):12-23.

Manasa A, Karimulla SK, Gobinath M. Ameliorative effect of Cleome gynandra Linn against scopolamine induced amnesia in mice. International Journal of Research in Pharmaceutical Sciences. 2017;8(4):642-649.

Salma A. Elsawi SA, Hanan FA, Elbatanony MM, Maamoun AA, Mowawad DM. Phytochemical evaluation of Lagerstroemia indica (L.) leaves as anti-alzheimer's. Journal of Material and Environmental Sciences. 2018;9(9):2575-2586.

Joshi H, Parle M. Evaluation of nootropic potential of Ocimum sanctum Linn. In mice. Indian journal of Experimental Biology. 2006;44(2):133-136.

Parameshwari K, Shashi kumar, Priyadharshini Bai G, Prathima C, Neetha C. Nootropic activity of ethanolic extract of Alangium salvifolium leaves on Scopolamine mouse model of Alzheimer’s disease. National Journal of Physiology, Pharmacy and Pharmacology. 2018;8(12):1625-1630.

Pramodinee D, Mahesh M, Niranjan D, Sankpala S. Memory enhancing activity of Cissampelos papiera in mice. International Journal of Pharmaceutical Sciences. 2011;3(2):206-211.

Faiyaz A, Narendra J, Sharath C. Acetylcholine and memory-enhancing activity of Ficus racemosa bark. Pharmacognosy Research. 2011;3(4):246-249.

Mani V, Milind P. Memory enhancing activity of Emblica officinalis Gaertn:An ayurvedic preparation. Physiology & Behavior. 2007; 91(1):46-54.

Ramachandran S, Sanjay S, Dhanaraju M. Antiamnesic effect of Piracetam potentiated with Emblica officinalis and Curcuma longa in aluminium induced neurotoxicity of Alzheimer’s disease. International Journal of Advanced Research. 2013;1(7):185-196.

Vasudevan M, Milind P. Memory enhancing activity of Coriandrum sativum in rats. Pharmacologyonline. 2009;2:827-839.

Maeda A, Tanimoto S, Abe T, Kazama S, Tanizawa H, Nomura M. Chemical constituents of Myristica fragrans Houttuyn seed and their physiological activities. Yakugaku Zasshi. 2008;128(1):129-133.

Parle M, Dhingra D, Kulkarni S. Improvement of mouse memory by Myristica fragrans seeds. Journal of Medicinal Food. 2004;7(2):157-161.

Narasimhan B, Dhake S. Antibacterial principles from Myristica fragrans seeds. Journal of Medicinal Food. 2009;9(3):395- 399.

Rashed K, Said A, Feitosa C, Sucupira ACC. Evaluation of anti-alzheimer activity of Ampelopsis brevipedunculata and the isolated compounds. Research Journal of Phytochemistry. 2015;9 (1):16-24.

Pandey SK, Sahay A, Panday RS, Tripathi YB. Effect of Asparagus racemosus rhizome [Shatavari] on mammary gland and genital organs of pregnant rat. Phytotherapy Research. 2005;19(8):721-724.

Jagdish P, Reena C, Pooja S, Maheep B. In vivo Investigation of antiamnesic effect of Asparagus racemosus root extract in scopolamine induced amnesic mice. International Journal of Herbal Medicine 2015;3(5):20-24.

Muralidharan P, Kumar VR, Balamurugan G. Protective effect of Morinda citrifolia fruits on β-amyloid (25-35) induced cognitive dysfunction in mice:an experimental and biochemical study. Phytotherapy Research. 2010;24(2):252-258.

Wang R, Yan H, Tang XC. Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine. Acta Pharmacologica Sinca. 2006;27(1):1-26.

Pachauri SD, Tota S, Khandelwal K, Verma PR, Nath C, Hanif K, Shukla R, Saxena JK, Dwivedi AK. Protective effect of fruits of Morinda citrifolia L. on scopolamine induced memory impairment in mice:a behavioral, biochemical and cerebral blood flow study. Journal of Ethnopharmacology. 2012;139(1): 34-41.

Kumar MH, Gupta YK. Antioxidant property of Celastrus paniculatus Willd:a possible mechanism in enhancing cognition. Phytomedicine. 2002;9(4):302-311.

Gattu M, Boss KL, Terry AV, Buccafusco JJ. Reversal of scopolamine-induced deficits in navigational memory performance by the seed oil of Celastrus paniculatus. Pharmacology Biochemistry and Behavior. 1997;57(4):793-799.

Lekha G, Kumar B P, Rao S N, Arockiasamy I, Mohan K. Cognitive enhancement and neuroprotective effect of Celastrus paniculatus Willd seed oil (Jyothismati oil) on male Wistar rats. Journal of Pharmaceutical Science and Technology. 2010;2(2):130-138.

Wake G, Court J, Pickering A, Lewis R, Wilkins R, Perry E. CNS acetylcholine receptor activity in European medicinal plants traditionally used to improve failing memory. Journal of Ethnopharmacology. 2000;69(2): 105-114.

Kennedy DO, Scholey AB, Tildesley NT, Perry EK, Wesnes KA. Modulation of mood and cognitive performance following acute administration of Melissa officinalis (lemon balm). Pharmacology Biochemistry and Behavior. 2002;72(4):953-964.

Akhondzadeh S, Noroozian M, Mohammadi M, Ohadinia S, Jamshidi A, Khani M. Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer’s disease:a double blind, randomised, placebo controlled trial. Journal of Neurology, Neurosurgery and Psychiatry. 2003;74(7):863-866.

Sivaraman D, Kumar P, Muralidharan P, Rahman H, Nagar I, Thoraipakkam C. Effect of Hemidesmus indicus on cerebral infract ischemia‐reperfusion injured rats by four vessel occlusion method. Pharmacologia. 2012;3(4): 91–102.

Kadiyala M, Ponnusankar S, Elango K. Screening of siddha medicinal plants for its in‐vitro acetylcholinesterase and butyrylcholinesterase inhibitory activity. Pharmacognosy Magazine. 2014;10(2):S294.

Shete R, Bodhankar S. Hemidesmus indicus: evaluation of its nootropic effect in mice. International Journal of Pharma and Bio Sciences. 2010;1(3):PS55.

Ankita S, Kaur P, Gupta R. Phytochemical screening and antimicrobial assay of various seeds extracts of Cucurbitaceae Family. International Journal of Applied Biology & Pharmaceutical Technology. 2012;3(3):401-409.

Patil MVK, Kandhare A, Bhise D. Pharmacological evaluation of ameliorative effect of aqueous extracts of Cucumis sativus L. fruit formation on wound healing in Wister rats. Chron young sci. 2011;2(4):207-213.

Sudheesh S, Vijayalakshmi NR. Role of pectin from cucumber (Cucumis sativus) in modulation of protein kinase C activity and regulation of glycogen metabolism in rats. Indian Journal of Biochemistry and Biophysics. 2007;44(3):183-5.

Sharma S, Dwivedi J, Paliwal S. Evaluation of antacid and carminative properties of Cucumis sativus under simulated conditions. Scholars Research Library Der Pharmacia Lettre. 2012;4(1):234-239.

Rodriguez N, Vasquez Y, Hussein AA, Coley PD, Solis PN, Gupta MP. Cytotoxic cucurbitacin constituents from Sloanea zuliaensis. Journal of Natural Product. 2003;66(11):1515-1516.

Sudheesh S, Vijayalakshmi N R. Lipid-lowering action of pectin from Cucumis sativus. Food Chemistry. 1999;67(3):281- 286.

Roman- Ramos R, Flores-Saez JL, Alarcon- Aguilar FJ. Anti-hyperglycaemic effect of some edible plants. Journal of Ethnopharmacology. 1995;48(1):25-32.

Recio MC, Prieto M, Bonucelli M, Orsi C, Manez S, Giner RM, Cerda-Nicolas M, Rios JL. Anti-inflammatory activity of two cucurbitacins isolated from Cayaponia tayuya roots. Planta Medica. 2004;70(5):414-420.

Sotiroudis G, Melliou E, Sotiroudis TG, Chinou I. Chemical analysis, antioxidant and antimicrobial activity of three greek cucumber (Cucumis sativus) cultivars. Journal of Food Biochemistry. 2010;34(1):61-78.

Kumar M, Garg A, Parle M. Amelioration of diazepam induced memory impairment by fruit of Cucumis sativus L. in aged mice by using animal models of alzheimer’s disease. International Journal of Pharmacognosy and Phytochemical Research. 2014-15;6(4);1015-1023.

Avinash P, Reddy A, Begum N, Bakshi V. Neuroprotective effect of Garcinia Mangostana on streptozotocin induced sporadic type alzheimer’s disease in mice. International Journal of Applied Pharmaceutical Sciences and Research. 2016;1(1):8-15.

Barua CC, Haloi P, Patowary P, Bora M, Barua AG, Bordoloi MJ, Barua IC. Evaluation of anti‐amnestic activity of few medicinal plants against scopolamine induced amnesia. Indian Journal of Traditional Knowledge. 2015;14(4): 581–589.

Vasudevan M, Parle M. Pharmacological actions of Thespesia populnea relevant to alzheimer’s disease. Phytomedicine. 2006; 13(9-10):677-687.

Ali S K, Hamed A R, Soltan M M, Hegazy U M, Elgorashi E E, El-Garf I A, Hussein A A. In-vitro evaluation of selected Egyptian traditional herbal medicines for treatment of Alzheimer disease. BMC Complementary and Alternative Medicine. 2013;13:121.

Shishodia S, Sethi G, Aggarwal BB. Curcumin:Getting back to the roots. Annals of the New York Academy of Sciences. 2005;1056:206-217.

Suganthy N, Pandian SK, Devi KP. Cholinesterase inhibitory effects of Rhizophora lamarckii, Avicennia officinalis, Sesuviu portulacastrum and Suaeda monica: Mangroves inhabiting an Indian coastal area (Vellar Estuary). Journal of Enzyme Inhibition and Medicinal Chemistry. 2009:24(3);702- 707.

Perry EK, Pickering AT, Wang WW, Houghton PJ, Perry NS. Medicinal plants and alzheimer’s disease: From ethnobotany to phytotherapy. Journal of Pharmacy and Pharmacology. 1999;51(5):527-534.

Vasudevan, M.;Parle, M. Antiamnesic potential of Murraya koenigii leaves. Phytotherapy Research. 2009;23(3):308-316.

Joshi H, Parle M. Antiamnesic effects of Desmodium gangeticum in mice. Yakugaku Zasshi. 2006;126(9):795-804.

Oh MH, Houghton PJ, Whang WK, Cho JH. Screening of Korean herbal medicines used to improve cognitive function for anticholinesterase activity. Phytomedicine. 2004;11(6):544-548.

Rao RV, Descamps O, John V, Bredesen D E. Ayurvedic medicinal plants for Alzheimer’s disease:A review. Alzheimer’s Research and Therapy. 2012;4(3):22-31.

Frydman-Marom A, Levin A, Farfara D, Benromano T, Scherzer-Attali R, Peled S, Vassar R, Segal D, Gazit E, Frenkel D, Ovadia M. Orally administrated cinnamon extract reduces β-amyloid oligomerization and corrects cognitive impairment in Alzheimer’s disease animal models. PLOS One. 2011; 6(1):e16564.

Conforti F, Statti GA, Tundis R, Loizzo MR, Menichini F. In vitro activities of Citrus medica L. cv. Diamante (Diamante citron) relevant to treatment of diabetes and Alzheimer’s disease. Phytotherapy Research. 2007;21(5):427-433.

Singhal AK, Naithani V, Bangar OP. Medicinal plants with a potential to treat Alzheimer and associated symptoms. International Journal of Nutrition, Pharmacology, Neurological Diseases. 2012;2:84-91.

Papandreou MA, Kanakis CD, Polissiou MG, Efthimiopoulos S, Cordopatis P. Inhibitory activity on amyloid-beta aggregation and antioxidant properties of Crocus sativus stigmas extract and its crocin constituents. Journal of Agriculture and Food Chemistry. 2006;54(23). 8762-8768.

Fujiwara H, Iwasaki K, Furukawa K, Seki T, He M. A traditional medicinal herb Paeonia suffruticosa and its active constituent 1,2,3,4,6-penta-O-galloyl-beta-D-glucopyranose have potent anti- aggregation effects on Alzheimer’s amyloid beta proteins in vitro and in vivo. Journal of Neurochemistry. 2009;109(6):1648-1657.

Fujiwara H, Iwasaki K, Furukawa K, Seki T, He M. Uncaria rhynchophylla, a Chinese medicinal herb, has potent antiaggregation effects on Alzheimer’s beta-amyloid proteins. Journal of Neuroscience Research. 2006; 84(2):427-433.

Kang IJ, Jeon YE, Yin XF, Nam JS, You SG. Butanol extract of Ecklonia cava prevents production and aggregation of beta-amyloid, and reduces beta-amyloid mediated neuronal death. Food and Chemical Toxicology. 2011; 49(9):2252-2259.

Ha GT, Wong RK, Zhang Y. Huperzine a as potential treatment of Alzheimer’s disease:an assessment on chemistry, pharmacology, and clinical studies. Chemistry & Biodiversity. 2011;8:1189.

Karuppagounder SS, Pinto JT, Xu H, Chen HL, Beal MF. Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer’s disease. Neurochemistry International. 2009;54(2):111-118.